Minimally Invasive Biopsy Technologies Market Size, Revenue Analysis, Industry Outlook, Forecast, 2021-2027

Comments · 184 Views

Growing demand for minimally invasive procedures in biopsy owing to its higher convenience is driving the demand for the market.

The Global Minimally Invasive Biopsy Technologies Market is projected to reach USD 3.98 billion in 2027. The market is expected to be driven due to a higher proliferation of the minimally invasive surgical procedures in biopsy testing and an extensive rise in the rate of breast and lung cancers globally. Around 66% of the total initial breast biopsies performed in North America are minimally invasive breast biopsies (MIBB).

The Minimally Invasive Biopsy Technologies Market intelligence report further offers hard to find data derived from attractiveness analysis that narrates a lot about the products, regions and applications expected to generate more revenue. The research study sheds light on the key growth opportunities and market trends along with other vital market dynamics, including the drivers and restraints on the industry growth. With this report, the prospective buyers can be sure to become capable of adapting to the changes in the Minimally Invasive Biopsy Technologies industry.


The extensive proliferation of the minimally invasive surgical technologies and extensive rise in the requirement of biopsy tests to diagnose cancerous cells and identifying infectious, autoimmune disorders and inflammatory cases. Early detection of the cancers and higher precision compared to incisional and excisional biopsies have been the constant driving factors for this market.

To learn about additional key drivers, trends, and challenges - Read our Sample Report right now! @

The major manufacturers covered in this report:

Chronix Biomedical, Biocept, Inc., F. Hoffmann-La Roche Ltd, Mauna Kea Technologies, Veracyte, Inc., Thermo Fisher Scientific, NeoGenomics Laboratories, Inc., Abcodia Ltd., Adaptive Biotechnologies, Owlstone Medical Ltd.

The research analyzes market segmentation based on product type, application, sale and geographical regions. All different parameters known to impact the Minimally Invasive Biopsy Technologies market are assessed in this research report and have also been accounted for, examined in detail, analyzed through qualitative and quantitative research and weighed upon to get actionable data.

Segments Covered in this report are:

  • Technology Outlook (Revenue: USD Billion; 2017-2027)
    • Liquid Biopsy
    • Optical Biopsy
    • Brush Biopsy
    • Pigmented Lesion Assays
    • Breath Biopsy
    • Brush Biopsy
    • Others
  • Therapeutic Application Outlook (Revenue: USD Billion; 2017-2027)
    • Lung Cancer
    • Breast Cancer
    • Prostate Cancer
    • Colorectal Cancer
    • Blood Cancer
    • Non-oncology Applications
  • End-Use Verticals Outlook (Revenue: USD Billion; 2017-2027)
    • Hospitals Clinics
    • Ambulatory Surgical Centers
    • Cancer Research Institutes
    • Others

!!! Limited Time DISCOUNT Available!!! Get Your Copy at Discounted Price@

Regional Outlook (Revenue: USD Billion; 2017-2027)

  • North America
    1. U.S.
    2. Canada
  • Europe
    1. UK
    2. Germany
    3. France
    4. BENELUX
  • Asia Pacific
    1. China
    2. Japan
    3. South Korea
    4. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • MEA
    1. Saudi Arabia
    2. UAE
    3. Rest of MEA

Further key findings from the report suggest

The ambulatory surgery centers have a more convenient outpatient procedure alternative to the hospital-based inpatient systems, maintaining a strong track record of quality care. Ambulatory surgery centers, incorporating all the required and modern MIB technologies, are expected to grow fastest amongst the end-use verticals throughout the forecast period.

The therapeutic application is further segmented into Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Blood Cancer, and Non-oncology Application. Minimally invasive breast biopsy (MIBB) has been highly recommended for the pre breast cancer diagnosis and checkup globally. The MIBB is expected to grow higher during the projected period as the number of breast cancer increases.

The Asia Pacific region, due to its immense rise in the breast lung cancers rising usage of the MIB technologies, is expected to accelerate with the fastest growth rate of 20.1% during the projected period 2020 to 2027.

Browse complete Minimally Invasive Biopsy Technologies report description And Full TOC @

Table of Contents:

Report Overview: It includes the objectives and scope of the study and gives highlights of key market segments and players covered. It also includes years considered for the research study.

Executive Summary: It covers industry trends with high focus on market use cases and top market trends, market size by regions, and global market size. It also covers market share and growth rate by regions.

Key Players: Here, the report concentrates on mergers and acquisitions, expansions, analysis of key players, establishment date of companies, and areas served, manufacturing base, and revenue of key players.

Breakdown by Product and Application: This section provides details about market size by product and application.

Regional Analysis: All of the regions and countries analyzed in the report are studied on the basis of market size by product and application, key players, and market forecast.

Profiles of International Players: Here, players are evaluated on the basis of their gross margin, price, sales, revenue, business, products, and other company details.

Market Dynamics: It includes supply chain analysis, analysis of regional marketing, challenges, opportunities, and drivers analyzed in the report.

Appendix: It includes details about research and methodology approach, research methodology, data sources, authors of the study, and a disclaimer.

Have Any Query? Ask Our Expert @

We are grateful to you for reading our report. If you wish to find more details of the report or want a customization, contact us. You can get a detailed information of the entire research here. If you have any special requirements, please let us know and we will offer you the report as you want.

Related Reports:

Aircraft Seals Market

Weather Alert and Warning Systems Market 

Radiation Therapy in Oncology Market

UAS Traffic Management System Market

Streaming Media Devices Market

Cool Roof Coating Market

Automotive Navigation Systems Market

Automotive Fuel Injection Systems Market

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Emergen Research Media Citations:

Visit for More Insights:

Explore Our Custom Intelligence services | Growth Consulting Services